key: cord-0711608-z9vz87ii authors: Pereson, Matías J.; Mojsiejczuk, Laura; Martínez, Alfredo P.; Flichman, Diego M.; Garcia, Gabriel H.; Di Lello, Federico A. title: Phylogenetic analysis of SARS‐CoV‐2 IN THE FIRST MONTHS SINCE ITS EMERGENCE date: 2020-09-23 journal: J Med Virol DOI: 10.1002/jmv.26545 sha: 048ed3b91a381bc472421640c5ced304b3cb3ed6 doc_id: 711608 cord_uid: z9vz87ii During the first months of SARS‐CoV‐2 evolution in a new host, contrasting hypotheses have been proposed about the way the virus has evolved and diversified worldwide. The aim of this study was to perform a comprehensive evolutionary analysis to describe the human outbreak and the evolutionary rate of different genomic regions of SARS‐CoV‐2. The molecular evolution in nine genomic regions of SARS‐CoV‐2 was analyzed using three different approaches: phylogenetic signal assessment, emergence of amino acid substitutions, and Bayesian evolutionary rate estimation in eight successive fortnights since the virus emergence. All observed phylogenetic signals were very low and tree topologies were in agreement with those signals. However, after four months of evolution, it was possible to identify regions revealing an incipient viral lineage formation despite the low phylogenetic signal, since fortnight 3. Finally, the SARS‐CoV‐2 evolutionary rate for regions nsp3 and S, the ones presenting greater variability, was estimated as 1.37 x 10(‐3) and 2.19 x 10(‐3) substitution/site/year, respectively. In conclusion, results from this work about the variable diversity of crucial viral regions and determination of the evolutionary rate are consequently decisive to understand essential features of viral emergence. In turn, findings may allow the first time characterization of the evolutionary rate of S protein, crucial for vaccine development. This article is protected by copyright. All rights reserved. The analysis of amino acid substitutions by fortnights was useful to study the viral evolutionary dynamics in the context of the beginning of the pandemic. When analyzing amino acid sequences from different time periods, changes were observed in 5 out of 9 genomic regions and only in 14 out of the 4975 (0.28%) evaluated residues. In most of the regions, except nsp1, nsp14, E, and Orf6, 2 to 6 amino acids emerge since FN3 and remain unchanged until the end of the follow-up period (Table 2 ). Particularly, in Orf8 region, early selection of two amino acid substitutions (V62L and L84S) was observed on FN2. On the other hand, in the S region, the D614G substitution started with less than 2% in FN3 and FN4 and reached 88% in the last fortnight. In a similar way, the Q57H (Orf3a) substitution increased from 6% to 34% while L84S (Orf8) start to be selected in FN2 and reached 6% at FN8. The R203K and G204R substitutions from the N region emerged in FN4 and increased their population proportion to values greater than 20% towards the end of the follow-up period. Moreover, the emergence of a great number of sporadic substitutions that This article is protected by copyright. All rights reserved. Article remains in the population for a short period (1-3 fortnights) was observed in the nine analyzed regions. Indeed, 333 (6.83%) positions from the total analyzed presented at least one substitution throughout the eight fortnights. Table 3 summarizes the number of variable positions, number of mutations, and number of sequences with mutations by region. In this study, trees were performed by Bayesian analysis instead of by distance, likelihood, or parsimony methods. Consistently with the phylogenetic signal analysis, trees for nsp1, E, and Orf6 showed a star-like topology. Nevertheless, different proportions of clade formation could be observed in trees of Orf8, nsp14, Orf3a, N, S, and nsp3 regions ( Figure 2 ). Finally, from the mentioned regions, nsp3 and S showed a better clade constitution. This analysis allowed to differentiate regions displaying a diversification process (nsp3, nsp14, Orf3a, S, Orf8, and N) from those that even after four months showed an incipient one (nsp1, E, and Orf6). Furthermore, this nucleotide analysis is complemented by the previous study of amino acid variations in each region. However, it is important to note that due to the low phylogenetic signal observed for each region, results can only be considered as preliminary. Nsp3 and S sequences were selected to perform the evolutionary rate analysis since both regions provided the best phylogenetic information among studied regions. The observed evolutionary rate for SARS-CoV-2 nsp3 protein was estimated as 1.37 x10 -3 nucleotide substitutions per site per year (s/s/y) (95% HPD interval 9.16 x10 -4 to Accepted Article [ This article is protected by copyright. All rights reserved. Epidemiology, genetic recombination, and pathogenesis of coronaviruses Coronavirus avian infectious bronchitis virus Origin and evolution of pathogenic coronaviruses A Novel Coronavirus from Patients with Pneumonia in China Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Transmission dynamics and evolutionary history of Genotyping coronavirus SARS-CoV-2: methods and implications A snapshot of SARS-CoV-2 genome availability up to 30th March, 2020 and its implications Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies The race for coronavirus vaccines: a graphical guide Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China The first two cases of 2019-nCoV in Italy: Where they come from Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 Moderate mutation rate in the SARS coronavirus genome and its implications From molecular genetics to phylodynamics: evolutionary relevance of mutation rates across viruses COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. bioRxiv